Payments to Acquire Property, Plant, and Equipment of LIFECORE BIOMEDICAL, INC. \DE\ from 30 May 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 May 2010 to 30 Sep 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Payments to Acquire Property, Plant, and Equipment for the quarter ending 30 Sep 2025 was $1,737,000, a 49% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Payments to Acquire Property, Plant, and Equipment for 2024 was $13,415,000, a 27% decline from 2023.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Payments to Acquire Property, Plant, and Equipment for 2023 was $18,395,000.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Payments to Acquire Property, Plant, and Equipment for 2021 was $26,226,000, a 36% increase from 2020.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,737,000 -$1,685,000 -49% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q3 2024 $3,422,000 -$1,632,000 -32% 27 May 2024 25 Aug 2024 10-Q 06 Nov 2025 2026 Q1
Q3 2023 $5,054,000 +$1,693,000 +50% 29 May 2023 27 Aug 2023 10-Q 04 Oct 2024 2025 Q1
Q3 2022 $3,361,000 -$4,552,000 -58% 30 May 2022 28 Aug 2022 10-Q 09 Aug 2024 2024 Q1
Q3 2021 $7,913,000 +$3,290,000 +71% 31 May 2021 29 Aug 2021 10-Q/A 16 Mar 2023 2022 Q1
Q3 2020 $4,623,000 -$5,358,000 -54% 01 Jun 2020 30 Aug 2020 10-Q 05 Oct 2021 2022 Q1
Q3 2019 $9,981,000 -$4,459,000 -31% 27 May 2019 25 Aug 2019 10-Q 07 Oct 2020 2021 Q1
Q3 2018 $14,440,000 +$8,713,000 +152% 28 May 2018 26 Aug 2018 10-Q 03 Oct 2019 2020 Q1
Q3 2017 $5,727,000 +$3,596,000 +169% 29 May 2017 27 Aug 2017 10-Q 05 Oct 2018 2019 Q1
Q3 2016 $2,131,000 -$1,356,000 -39% 30 May 2016 28 Aug 2016 10-Q 28 Sep 2017 2018 Q1
Q3 2015 $3,487,000 -$611,000 -15% 01 Jun 2015 30 Aug 2015 10-Q 29 Sep 2016 2017 Q1
Q3 2014 $4,098,000 -$247,000 -5.7% 02 Jun 2014 31 Aug 2014 10-Q 01 Oct 2015 2016 Q1
Q3 2013 $4,345,000 +$2,316,000 +114% 27 May 2013 25 Aug 2013 10-Q 08 Oct 2014 2015 Q1
Q3 2012 $2,029,000 +$468,000 +30% 28 May 2012 26 Aug 2012 10-Q 26 Sep 2013 2014 Q1
Q3 2011 $1,561,000 -$115,000 -6.9% 30 May 2011 28 Aug 2011 10-Q/A 02 Jan 2013 2013 Q1
Q3 2010 $1,676,000 01 Jun 2010 29 Aug 2010 10-Q 05 Oct 2011 2012 Q1

LIFECORE BIOMEDICAL, INC. \DE\ Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $13,415,000 -$4,980,000 -27% 27 May 2024 25 May 2025 10-KT 16 Mar 2026 2025 FY
2023 $18,395,000 29 May 2023 26 May 2024 10-KT 16 Mar 2026 2025 FY
2021 $26,226,000 +$6,962,000 +36% 31 May 2021 29 May 2022 10-K/A 16 Mar 2023 2022 FY
2020 $19,264,000 +$7,050,000 +58% 01 Jun 2020 30 May 2021 10-K/A 16 Mar 2023 2022 FY
2019 $12,214,000 -$32,520,000 -73% 27 May 2019 31 May 2020 10-K/A 16 Mar 2023 2022 FY
2018 $44,734,000 +$11,144,000 +33% 28 May 2018 26 May 2019 10-K 29 Jul 2021 2021 FY
2017 $33,590,000 +$10,587,000 +46% 29 May 2017 27 May 2018 10-K 14 Aug 2020 2020 FY
2016 $23,003,000 -$16,692,000 -42% 30 May 2016 28 May 2017 10-K 01 Aug 2019 2019 FY
2015 $39,695,000 +$22,184,000 +127% 01 Jun 2015 29 May 2016 10-K 09 Aug 2018 2018 FY
2014 $17,511,000 +$2,625,000 +18% 26 May 2014 31 May 2015 10-K/A 15 Mar 2018 2017 FY
2013 $14,886,000 +$6,009,000 +68% 27 May 2013 25 May 2014 10-K 01 Aug 2016 2016 FY
2012 $8,877,000 +$3,506,000 +65% 28 May 2012 26 May 2013 10-K 31 Jul 2015 2015 FY
2011 $5,371,000 -$1,313,000 -20% 30 May 2011 27 May 2012 10-K 01 Aug 2014 2014 FY
2010 $6,684,000 +$1,492,000 +29% 31 May 2010 29 May 2011 10-K 07 Aug 2013 2013 FY
2009 $5,192,000 01 Jun 2009 30 May 2010 10-K 08 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.